1/2 IMPACt-LBP CCC
1/2 IMPACt-LBP CCC
基本信息
- 批准号:10093277
- 负责人:
- 金额:$ 95.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-15 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAgeAmbulatory CareAmericanAmerican College of PhysiciansCaringCategoriesChronic low back painClient satisfactionClinicClinicalClinical ResearchClinical Trials DesignClinical trial protocol documentCluster randomized trialCollaborationsData Coordinating CenterDoctor of ChiropracticDocumentationDrug PrescriptionsEmergency department visitEvaluationExerciseFocus GroupsFoundationsFutureGoalsGuidelinesHealth Care CostsHealth systemHealthcare SystemsHospitalizationInfrastructureInjectionsInterventionInterviewIowaLeadLow Back PainMeasuresMedicalMedical Care CostsMedical centerMethodsModelingMusculoskeletalOperative Surgical ProceduresOpioidOrganizational PolicyPainPain interferencePain managementPain qualityPatient CarePatientsPhasePhysical FunctionPhysiciansPoliciesPrimary Health CareProceduresProcessProtocols documentationProviderQuality-Adjusted Life YearsRandomized Clinical TrialsRandomized Controlled TrialsReportingResearch DesignResearch InstituteResourcesRiskSiteSourceSpinal FusionSpinal ManipulationStandardizationSurveysSystemTestingTimeTrainingUniversitiesVisitWorkbasecare providerschronic painclinical research sitecollaborative carecomparative effectivenesscompare effectivenesscostdisability impacteffectiveness testingexperiencefunctional statushealth care service utilizationhealth service useimplementation facilitationimplementation trialimprovedincremental cost-effectivenessinformantmembermultidisciplinaryopioid epidemicopioid mortalityopioid usepain reductionphysical therapistprescription opioidprimary endpointprimary outcomesecondary outcomeservice utilizationsymptom treatmenttreatment as usualuptake
项目摘要
Low back pain (LBP) is a key source of medical costs and disability, impacting over 31 million Americans at
any given time and resulting in $100-$200 billion per year in total healthcare costs. LBP is one of the leading
causes of ambulatory care visits to US physicians; unfortunately, these visits often result in treatments such as
opioids that can lead to more harm than benefit. In 2017 the American College of Physicians (ACP) guideline
for LBP recommended patients receive non-pharmacological interventions as a first-line treatment but stopped
short of offering solutions regarding how such treatments should be integrated into routine patient care.
Roadmaps exist for multi-disciplinary collaborative care that includes doctors of chiropractic and physical
therapists, well-trained primary contact clinicians with specific expertise in the treatment of musculoskeletal
conditions, as first line providers for LBP. These clinicians routinely employ many of the non-pharmacological
approaches recommended by the ACP guideline, including spinal manipulation and exercise. Important
foundational work conducted by members of the study team has demonstrated that such care is feasible, safe,
and results in improved physical function, less pain, fewer opioid prescriptions, and reduced utilization of
healthcare services. However, this treatment approach for LBP has yet to be widely implemented or validated
using rigorous scientific methods. Our overarching goal is to refine and implement a multidisciplinary
collaborative care model for LBP (MC2LBP) in 3 academic Health Care Systems (HCS) and then evaluate its
effectiveness by comparing it to usual medical care in patients age 18 and older suffering from LBP.
Completion of project study aims will begin with a one-year UG3 planning phase involving completion of 22
milestones in 2 categories of phased activities - model implementation and clinical trial design. UH3 study aims
will be accomplished using a pragmatic, cluster-randomized, clinical trial design. The study will be managed
through a Clinical Coordinating Center and Data Coordinating Center, both housed at the Duke Clinical
Research Institute, in collaboration with Dartmouth-Hitchcock Medical Center and the University of Iowa.
During the planning phase, we will build implementation infrastructure across three HCS, finalize the clinical
trial protocol, and complete the tasks necessary to transition from the UG3 to UH3 phase. The UH3 phase will
be used to: 1) Operationalize the integration of new organizational policies and procedures required to facilitate
implementation of MC2LBP at intervention clinics; 2) Determine the comparative effectiveness of MC2LBP vs
usual care; 3) Estimate and compare medical resource use and costs of implementing MC2LBP; and 4)
Evaluate patient, provider, system and policy level barriers and facilitators to implementing MC2LBP, using a
mixed method, process evaluation approach. Results from this study have the potential to inform future
implementation and policy efforts to improve the quality of pain management for patients suffering from LBP
while simultaneously reducing opioid prescriptions, health care costs and utilization of services.
腰痛(LBP)是医疗费用和残疾的主要来源,影响着3100多万美国人
在任何给定的时间内,每年都会产生1,000-2,000亿美元的总医疗成本。LBP是领先的
导致门诊护理就诊的美国医生;不幸的是,这些就诊经常导致治疗,如
可能弊大于利的阿片类药物。2017年美国医师学会(ACP)指南
对于推荐的LBP患者,将非药物干预作为一线治疗,但已停止
缺乏关于如何将这些治疗融入常规患者护理的解决方案。
多学科协作护理的路线图已经存在,其中包括脊椎按摩和理疗医生
治疗师,训练有素的初级接触临床医生,在肌肉骨骼治疗方面具有特定专业知识
条件,作为LBP的一线提供者。这些临床医生例行公事地雇用许多非药理学的
ACP指南推荐的方法,包括脊柱手法和锻炼。重要
研究小组成员进行的基础性工作表明,这种护理是可行的、安全的、
并导致改善身体功能,减轻疼痛,减少阿片类药物处方,并减少对
医疗保健服务。然而,这种治疗LBP的方法尚未得到广泛的实施或验证
使用严谨的科学方法。我们的总体目标是完善和实施多学科
3种学术卫生保健系统中的LBP协作护理模型(MC2LBP)及其评价
通过将其与18岁及以上患有LBP的患者的常规医疗护理进行比较,得出其有效性。
完成项目研究的目标将从为期一年的UG3规划阶段开始,包括完成22
两类阶段性活动的里程碑--模型实施和临床试验设计。UH3研究目标
将使用务实的、整群随机的临床试验设计来完成。这项研究将得到管理
通过临床协调中心和数据协调中心,这两个中心都位于杜克临床
该研究所与达特茅斯-希区柯克医学中心和爱荷华大学合作。
在规划阶段,我们将在三个HC中构建实施基础设施,最终确定临床
试验方案,并完成从UG3过渡到UH3阶段所需的任务。UH3阶段将
用于:1)实现新组织政策和程序的集成,以促进
MC2LBP在干预诊所的实施情况;2)比较MC2LBP与
日常护理;3)估计和比较实施MC2LBP的医疗资源使用和成本;以及4)
评估患者、提供者、系统和政策层面实施MC2LBP的障碍和促进者,使用
混合法、过程性评价法。这项研究的结果有可能为未来
改善下腰痛患者疼痛管理质量的实施和政策努力
同时减少阿片类药物处方、医疗保健成本和服务利用率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adam Goode其他文献
Adam Goode的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adam Goode', 18)}}的其他基金
1/2 IMPACt-LBP CCC-Administrative Supplements for Complementary Health Practitioner Research Experience
1/2 IMPACt-LBP CCC-补充健康从业者研究经验的行政补充
- 批准号:
10710788 - 财政年份:2023
- 资助金额:
$ 95.84万 - 项目类别:
1/2 IMPACt-LBP CCC-Administrative Supplements for Complementary Health Practitioner Research Experience
1/2 IMPACt-LBP CCC-补充健康从业者研究经验的行政补充
- 批准号:
10856432 - 财政年份:2021
- 资助金额:
$ 95.84万 - 项目类别:
Preventing Disability from MSK Pain in Northern Tanzania
预防坦桑尼亚北部 MSK 斯隆疼痛造成的残疾
- 批准号:
10264053 - 财政年份:2020
- 资助金额:
$ 95.84万 - 项目类别:
Biomarkers to Advance Clinical Phenotypes of Low Back Pain (BACk)
促进腰痛 (BACk) 临床表型的生物标志物
- 批准号:
9445928 - 财政年份:2017
- 资助金额:
$ 95.84万 - 项目类别:
Biomarkers to Advance Clinical Phenotypes of Low Back Pain (BACk)
促进腰痛 (BACk) 临床表型的生物标志物
- 批准号:
9755361 - 财政年份:2017
- 资助金额:
$ 95.84万 - 项目类别:
Biomarkers to Advance Clinical Phenotypes of Low Back Pain (BACk)
促进腰痛 (BACk) 临床表型的生物标志物
- 批准号:
10735846 - 财政年份:2017
- 资助金额:
$ 95.84万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 95.84万 - 项目类别:
Directed Grant














{{item.name}}会员




